ReviewCurrent atherosclerosis reports2025

Semaglutide and Tirzepatide for the Treatment of Obesity and Weight-Related Comorbidities: A Narrative Review.

Zeb Ijaz Saeed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.